Speaker illustration

Doctor Sokrates Stein

University of Zurich, Zurich (Switzerland)

PD Dr. Sokrates Stein grew up in Brazil, studied Biology at the University of Tübingen, Germany, received his PhD from the University of Zurich, and conducted his postdoctoral work at the École Polytechnique Fédérale de Lausanne, Switzerland. From 2016 to 2020he was a research group leader at the Center for Molecular Cardiology at the University of Zurich. Since June 2020 he works as a medical advisor for Novartis Pharma Schweiz. Dr. Stein has a track record in basic cardiovascular research, with special focus on deciphering new molecular mechanisms that regulate atherosclerosis and to implement new translational approaches for cardiovascular diseases.

Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability

Event: ESC CONGRESS 2019

Topic: Vascular Diseases: Fibrosis

Session: Atherosclerosis and vascular dysfunction


This platform is supported by

logo Novo Nordisk